Development and evaluation of HIV-1 subtype RNA panels for the standardization of HIV-1 NAT assays

Journal of Virological Methods

Volumn 137, Issue 2, 2006, Pages 287-291

  Lee, Sherwin ^a   Wood, Owen ^a   Taffs, Rolf E ^b   Hu, Jinjie ^a   Machuca, Ana ^a   Vallejo, Alejandro ^a   Hewlett, Indira ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b Parasite and Allergenic Products   (United States)

Author keywords

HIV 1 RNA; International standard; NAT; Working reagents

Indexed keywords

VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; STANDARDIZATION; STATISTICAL ANALYSIS; VALIDATION PROCESS; VIRUS ISOLATION;

GENETIC TECHNIQUES; HIV-1; HUMANS; REFERENCE STANDARDS; RNA STABILITY; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33748872692     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.07.001     Document Type: Article

References (11)

1. Bibollet-Ruche F., Peeters M., Mboup S., Ekaza E., Gandji R., Torimiro J., Mpoudi E.N., Amblard J., Dibanga G., Saidou M., Esu-Williams E., Van den Haesevelde M., Saman E., and Delaporte E. Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries. AIDS Res. Hum. Retroviruses 14 14 (1998) 1281-1285
2. Busch M., Glynn S., Stramer S., Strong D., Caglioti S., Wright D., Pappalardo B., and Kleinman S. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45 (2005) 254-263
3. Corbet S., Muller-Trutwin M., Versmisse P., Delarue S., Ayouba A., Lewis J., Brunak S., Martin P., Brun-Vezinet F., Simon F., Barre-Sinoussi F., and Mauclere P. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same area. J. Virol. 74 1 (2000) 529-534
4. Gao F., Yue L., Craig S., Thornton C.L., Robertson D.L., McCutcheon F.E., Bradac J.A., Sharp P.M., and Hahn B.H. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E WHO network for HIV isolation and characterization. AIDS Res. Hum. Retroviruses 10 11 (1994) 1359-1368
5. Gurtler L.G., Zekeng L., Simon F., Eberle J., Tsague J.M., Kaptue L., Brust S., and Knapp S. Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots. Virol. Methods 51 2-3 (1995) 177-183
6. Mellors J.W., Munoz A., Giorgi J.V., Margolick J.B., Tassoni C.J., Gupta P., Kingsley L.A., Todd J.A., Saah A.J., Detels R., Phair J.P., and Rinaldo Jr. C.R. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Internet Med. 126 12 (1997) 946-954
7. Mellors J.W., Kingsley L.A., Rinaldo Jr. C.R., Todd J.A., Hoo B.S., Kokka R.P., and Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Internet Med. 22 8 (1995) 573-579
8. O'Brien W.A., Hartigan P.M., Daar E.S., Simberkoff M.S., and Hamilton J.D. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure VA cooperative study group on AIDS. Ann. Internet Med. 126 12 (1997) 939-945
9. Phelps R., Robbins K., Liberti T., Machuca A., Leparc G., Chamberland M., Kalish M., Hewlett I., Folks T., Lee L., and McKenna M. Window period human immunodifficiency virus transmission in two recipients by an adolescent blood donor. Transfusion 44 (2004) 923-929
10. Schuurman R., Nijhuis M., van Leeuwen R., Schipper P., de Jong D., Collis P., Danner S.A., Mulder J., Loveday C., Christopherson C., et al. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171 6 (1995) 1411-1419
11. UNAIDS, 2004. United Nations Aids Epidemic. UNAIDS Information Center, Geneva, Switzerland.